2024 annual financial data
Ovid Therapeutics 2024 Net margin
Direct answer
Net margin was -4,670.14%.
Operating income was -61,885,000 USD and net income was -26,433,000 USD.
Operating cash flow was -55,956,000 USD.
Get free Ovid Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 566,000 USD
- Operating income
- -61,885,000 USD
- Net income
- -26,433,000 USD
- Operating cash flow
- -55,956,000 USD